IRONWOOD PHARMACEUTICALS, INC. (IRWD) Net income 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$24.0MFY2025 · since FY2016: -$81.7M → $24.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.0M | +2629.2% |
| FY2024 | $880,000 | +100.1% |
| FY2023 | -$1.0B | -672.5% |
| FY2022 | $175.1M | -66.9% |
| FY2021 | $528.4M | +397.7% |
| FY2020 | $106.2M | +393.7% |
| FY2019 | $21.5M | +107.6% |
| FY2018 | -$282.4M | -141.5% |
| FY2017 | -$116.9M | -43.1% |
| FY2016 | -$81.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →